Clinical trials
Phase 3 Macular Degeneration trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Ophthotech Corporation | 2 |
| 4D Molecular Therapeutics | 1 |
| Allergan | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Bayer | 1 |
| Genentech, Inc. | 1 |
| IVERIC bio, Inc. | 1 |
| Opthea Limited | 1 |
| Outlook Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 15 |
| Geographic Atrophy | 5 |
| Wet Macular Degeneration | 5 |
| Choroidal Neovascularization | 4 |
| Eye Diseases | 3 |
| Retinal Diseases | 3 |
| Vision Disorders | 3 |
| Retinal Degeneration | 2 |
| Blindness | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.